Breakdown | ||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
9.99M | 8.93M | 18.62M | 14.36M | 10.77M | Gross Profit |
-512.52K | -948.87K | 1.67M | 2.18M | 1.03M | EBIT |
-9.28M | -6.04M | -1.77M | 1.52M | 648.95K | EBITDA |
-8.79M | -5.74M | -1.36M | 1.71M | 678.63K | Net Income Common Stockholders |
-12.79M | -7.34M | -2.46M | 1.14M | 464.98K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
70.50M | 221.76K | 810.37K | 1.31M | 489.85K | Total Assets |
70.50M | 14.20M | 20.85M | 11.80M | 11.27M | Total Debt |
0.00 | 8.06M | 6.25M | 136.48K | 88.50K | Net Debt |
-456.15K | 7.84M | 5.44M | -1.18M | -401.35K | Total Liabilities |
2.44M | 20.92M | 20.23M | 10.03M | 10.72M | Stockholders Equity |
68.05M | -6.72M | 617.45K | 1.77M | 555.69K |
Cash Flow | Free Cash Flow | |||
-4.03M | -1.68M | -2.51M | 2.05M | 395.29K | Operating Cash Flow |
-4.03M | -1.68M | -2.45M | 2.07M | 466.21K | Investing Cash Flow |
-219.80K | -437.09K | -269.77K | -1.19M | -216.93K | Financing Cash Flow |
3.57M | 1.53M | 2.22M | 41.85K | 100.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | $39.31M | 1.97 | 26.72% | ― | -8.81% | ― | |
64 Neutral | $12.82B | 9.83 | 7.68% | 17000.34% | 12.38% | -5.56% | |
55 Neutral | $17.82M | ― | -0.26% | ― | 48.84% | 98.75% | |
42 Neutral | $18.69M | ― | -109.72% | ― | -83.96% | 29.71% | |
35 Underperform | $651.44K | 0.03 | 108.03% | ― | ― | ― | |
35 Underperform | $7.28M | ― | 220.90% | ― | -92.71% | 39.07% |
On May 6, 2025, Nature’s Miracle Holding Inc. entered into an Equity Financing Agreement with GHS Investments, LLC, allowing for an equity line of credit up to $20 million over 24 months. This agreement, along with a Securities Purchase Agreement for Series A Preferred Stock, aims to bolster the company’s financial position and support its growth in the agriculture technology sector. The financing arrangement includes the issuance of common and preferred shares, with specific terms to manage ownership limits and conversion rights, potentially impacting the company’s market operations and stakeholder interests.
Spark’s Take on NMHI Stock
According to Spark, TipRanks’ AI Analyst, NMHI is a Underperform.
Nature’s Miracle Holding is currently struggling with severe financial instability, as evidenced by declining revenues, negative margins, and high leverage. The technical indicators show a bearish trend, though the oversold condition might attract short-term interest. The valuation metrics are poor, with a negative P/E ratio and no dividend yield. These factors collectively result in a low overall stock score, highlighting significant risks for potential investors.
To see Spark’s full report on NMHI stock, click here.
On February 13, 2025, Wenbing Chris Wang resigned from his position as Chief Financial Officer at Nature’s Miracle Holding Inc., a decision effective immediately. This resignation comes shortly after his appointment on January 7, 2025. The company has confirmed that George Yutuc will continue in his dual role as Chief Financial Officer and Chief Operating Officer, maintaining stability in its financial leadership. The separation agreement with Mr. Wang includes provisions for pro-rated compensation and unreimbursed expenses, with both parties agreeing to confidentiality and mutual release terms.